SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ajanta Pharma’s promoter acquires 18,169 shares in past three trading sessions

08 May 2013 Evaluate

Gabs Investments, one of the promoters of Ajanta Pharma has acquired 18,169 shares worth Rs 1.43 crore of the company through open market transaction in past three trading sessions.

Since April, Gab Investments had purchased 52,043 shares of the company taking its total holding in the company to 9.13% from 8.91% at the end of March quarter. In last financial year 2012-13, the promoters have raised their holdings in the company by 2.87 percentage points to 73% from 70.13%.

Ajanta Pharma Share Price

2790.15 -37.95 (-1.34%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×